"People should still go and get their COVID-19 vaccine when asked to do so," Phil Bryan, the agency's vaccines safety lead, was quoted as saying in a statement.
The drug regulator insisted there was no proof that reports of blood clots in Denmark, which halted the use of AstraZeneca for two weeks on Thursday, was caused by the UK-Swedish vaccine.
Bryan argued that blood clots were "not uncommon." Over 11 million doses of the vaccine have been administrated across the UK and the number of vaccinated people developing blood clots was not greater than would have occurred naturally.
Austria banned the use of the shot from a batch of 1 million doses after a vaccinated woman died of thrombosis days. It was followed by Denmark, Estonia, Iceland, Italy, Latvia, Lithuania, Luxembourg and Norway.
The European Medicines Agency (EMA) said on Thursday that it was investigating after two people inoculated from the same batch of AstraZeneca Covid-19 vaccine died from blood clotting and several countries stopped using the jabs.
ReplyDeleteThe inquiry comes after Iceland, Norway, Denmark, Estonia, Lithuania, Luxembourg and Latvia all suspended their rollouts of the AstraZeneca vaccine over fears that they may induce blood clotting – known medically as "thromboembolic events."
"There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine," the EMA said in a statement, adding that its own risk assessment committee was investigating the matter.